Moderna

Moderna is a biotechnology company that develops and commercializes medicines based on messenger RNA technology. Its operating model integrates mRNA design, drug discovery, clinical development, manufacturing, and commercialization through a common technology platform. The company markets vaccines for respiratory diseases while advancing clinical programs across infectious diseases, oncology, and rare diseases. Its pipeline includes respiratory and latent-virus vaccines, personalized cancer therapies, cancer antigen treatments, and therapeutics designed to produce proteins within the body. Moderna also develops programs through collaborations with pharmaceutical and research organizations. Its strategic focus centers on applying shared mRNA technologies, delivery systems, and manufacturing processes across multiple therapeutic areas.